Ibrutinib increases the risk of atrial fibrillation, potentially through inhibition of cardiac PI3K-Akt signaling Letter uri icon

authors

  • McMullen, JR
  • Boey, EJH
  • Ooi, JYY
  • Seymour, JF
  • Keating, MJ
  • Tam, CS

publication date

  • December 11, 2014

has subject area

published in